1. CALHM1 ion channel elicits amyloid-β clearance by insulindegrading enzyme in cell lines and in vivo in the mouse brain.
- Author
-
Vingtdeux, Valérie, Chandakkar, Pallavi, Zhao, Haitian, Blanc, Lionel, Ruiz, Santiago, and Marambaud, Philippe
- Subjects
- *
ALZHEIMER'S disease , *CALCIUM channels , *CELL lines , *AMYLOID beta-protein , *INSULINASE , *BRAIN physiology , *LABORATORY mice - Abstract
Alzheimer's disease is characterized by amyloid-ß (Aβ) peptide accumulation in the brain. CALHM1, a cell-surface Ca²+ channel expressed in brain neurons, has anti-amyloidogenic properties in cell cultures. Here, we show that CALHM1 controls Aβ levels in vivo in the mouse brain through a previously unrecognized mechanism of regulation of Aβ clearance. Using pharmacological and genetic approaches in cell lines, we found that CALHM1 ion permeability and extracellular Ca²+ were required for the Aβ-lowering effect of CALHM1. Aβ level reduction by CALHM1 could be explained by an increase in extracellular Aβ degradation by insulin-degrading enzyme (IDE), extracellular secretion of which was strongly potentiated by CALHM1 activation. Importantly, Calhml knockout in mice reduced IDE enzymatic activity in the brain, and increased endogenous Aβ concentrations by up to ~50% in both the whole brain and primary neurons. Thus, CALHM1 controls Aβ levels in cell lines and in vivo by facilitating neuronal and Ca²+-dependent degradation of extracellular Aβ by IDE. This work identifies CALHM1 ion channel as a potential target for promoting amyloid clearance in Alzheimer's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF